Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 201–300 of 999
Clonal germinal center B cells function as a niche for T-cell lymphoma
Fujisawa, M., Nguyen, T. B., Abe, Y., Suehara, Y., Fukumoto, K., Suma, S., Makishima, K., Kaneko, C., Nguyen, Y. T. M., Usuki, K., et al. (2022) · Blood · doi:10.1182/blood.2022015451 · Cited by 67
Xin, S., Liu, X., Li, Z., Sun, X., Wang, R., Zhang, Z., Feng, X., Jin, L., Li, W., Tang, C., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00407-0 · Cited by 72
“B cells were divided into two categories: one with center cell/glial cell-expressing characteristics and the other with naive B lymphocyte expression characteristics [44], which shows B cell heterogeneity in the tumor tissue.”
BackgroundComprehensive analysis of metastatic gastric cancer tumour cells using single-cell RNA-seq
Wang, B., Zhang, Y., Qing, T., Xing, K., Li, J., Zhen, T., Zhu, S., & Zhan, X. (2021) · Scientific Reports · doi:10.1038/s41598-020-80881-2 · Cited by 64
Decoding Cancer Biology One Cell at a Time
Castro, L. N. G., Tirosh, I., & Suvà, M. L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1376 · Cited by 59
Walter, V. P., Fischer, C., Deutsch, T. M., Ersing, C., Nees, J., Schütz, F., Fremd, C., Grischke, E., Sinn, H., Brucker, S. Y., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05746-8 · Cited by 66
Zhu, Z., Jiang, L., & Ding, X. (2023) · Cancers · doi:10.3390/cancers15164164 · Cited by 77
“Nevertheless, in comparison to luminal subtypes, HER2-enriched tumor cells lie closer to the TNGA continuum and manifest pronounced levels of stemness and recurrence traits [8].”
BackgroundInfluentialDENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing
Zhou, Z., Xu, B., Minn, A. J., & Zhang, N. R. (2020) · Genome biology · doi:10.1186/s13059-019-1922-x · Cited by 66
Kvokačková, B., Remšík, J., Jolly, M. K., & Souček, K. (2021) · Cancers · doi:10.3390/cancers13092188 · Cited by 69
“Immune cells, particularly tumor-infiltrating lymphocytes are often implicated in TNBC prognosis [44,45] and such a complex immune landscape is composed of specific B cell populations, tissue macrophages and T-lymphocytes with distinct transcriptomic signatures including naïve/early costimulatory, exhausted, or cytoto…”
BackgroundBioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis
Li, Y., Zhao, X., Liu, Q., & Liu, Y. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1914343 · Cited by 72
Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies
Zhao, N., & Rosen, J. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.07.010 · Cited by 62
Wang, T., Dang, N., Tang, G., Li, Z., Li, X., Shi, B., Xu, Z., Li, L., Yang, X., Xu, C., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13190 · Cited by 65
‘Omics Approaches to Explore the Breast Cancer Landscape
Parsons, J., & Francavilla, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00395 · Cited by 63
Peng, J., Wang, X., & Shang, X. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2769-6 · Cited by 56
Kawakami, R., Mashima, T., Kawata, N., Kumagai, K., Migita, T., Sano, T., Mizunuma, N., Yamaguchi, K., & Seimiya, H. (2020) · Cancer Science · doi:10.1111/cas.14316 · Cited by 62
Yuan, X. F., Wang, J., Huang, Y., Shangguan, D., & Zhang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643692 · Cited by 62
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
Nath, A., Cosgrove, P. A., Mirsafian, H., Christie, E. L., Pflieger, L. T., Copeland, B., Majumdar, S., Cristea, M. C., Han, E. S., Lee, S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23171-3 · Cited by 62
Cheng, J., Liao, J., Shao, X., Lu, X., & Fan, X. (2021) · Advanced Science · doi:10.1002/advs.202101229 · Cited by 62
Identification of cancer subtypes from single-cell RNA-seq data using a consensus clustering method
Gan, Y., Li, N., Zou, G., Xin, Y., & Guan, J. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0433-z · Cited by 61
Xue, D., Tabib, T., Morse, C., & Lafyatis, R. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.11.012 · Cited by 58
Bosisio, F. M., Antoranz, A., van Herck, Y., Bolognesi, M. M., Marcelis, L., Chinello, C., Wouters, J., Magni, F., Alexopoulos, L., Stas, M., et al. (2020) · eLife · doi:10.7554/elife.53008 · Cited by 54
Integrated analysis of tumor-associated macrophage infiltration and prognosis in ovarian cancer
Tan, Q., Liu, H., Xu, J., Mo, Y., Wu, C., & Dai, F. (2021) · Aging · doi:10.18632/aging.203613 · Cited by 79
Zhang, C., He, H., Hu, X., Liu, A., Huang, D., Xu, Y., Chen, L., & Xu, D. (2019) · Aging · doi:10.18632/aging.102434 · Cited by 54
“Recent advances in single-cell RNA sequencing (scRNA-seq) have facilitated the transcriptional classification of cell types in many malignancies, including pancreatic ductal adenocarcinoma (PDAC), breast cancer and lung cancer [13, 14].”
BackgroundSingle cell RNA sequencing for breast cancer: present and future
Ren, L., Li, J., Wang, C., Lou, Z., Gao, S., Zhao, L., Wang, S., Chaulagain, A., Zhang, M., Li, X., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00485-1 · Cited by 61
Ng, J. C.-F., Quist, J., Grigoriadis, A. E., Malim, M. H., & Fraternali, F. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1316 · Cited by 62
“Values were centred and scaled by cohort before performing this procedure on a list of perplexity values: [2, 5, 10, 20, 30, 40, 50, 100].”
MethodGao, Y., Li, L., Amos, C. I., & Li, W. (2021) · Genome Research · doi:10.1101/gr.271346.120 · Cited by 56
“To illustrate scDaPars ’ capacity of characterizing single-cell APA variations in cancers, we applied scDaPars to a Smart-seq2 (Picelli et al. 2013) scRNA-seq data set containing 563 single cells from 11 breast cancer patients (Chung et al. 2017).”
MethodResultMammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis
Saeki, K., Chang, G., Kanaya, N., Wu, X., Wang, J., Bernal, L., Ha, D., Neuhausen, S. L., & Chen, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02201-2 · Cited by 48
Omics Technologies Improving Breast Cancer Research and Diagnostics
Orsini, A., Diquigiovanni, C., & Bonora, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612690 · Cited by 52
“To understand the complexity of the tumor immune microenvironment (TIME), specific studies have been conducted on tissue-resident memory T and B cells [73,74], allowing a better understanding of the general characteristics of immune cells in BC, revealing the vast diversity in the immune cells of both the adaptive and…”
BackgroundCell-level somatic mutation detection from single-cell RNA sequencing
Vu, T. N., Nguyen, H.-N., Calza, S., Kalari, K. R., Wang, L., & Yudi Pawitan, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz288 · Cited by 60
“1 Breast cancer patient dataset The full dataset from Chung et al. (2017) contains 11 breast cancer patients from different (predicted) molecular subtypes Luminal A, Luminal B, HER2-enriched and Basal-like.”
BackgroundDeciphering Human Tumor Biology by Single-Cell Expression Profiling
Tirosh, I., & Suvà, M. L. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055609 · Cited by 56
Digitaldlsorter: Deep-Learning on scRNA-Seq to Deconvolute Gene Expression Data
Torroja, C., & Sánchez‐Cabo, F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00978 · Cited by 58
“The breast cancer (BC) experiment has 10 samples from different tumor etiology and stages (Chung et al., 2017) ( Table 1 , GSE75688) and the colorectal cancer (CRC) experiment has 11 samples (Li et al., 2017b) ( Table 2 , GSE81861).”
InfluentialProgress and applications of single-cell sequencing techniques
Yasen, A., Aini, A., Wang, H., Li, W., Zhang, C., Ran, B., Tuxun, T., Maimaitinijiati, Y., Shao, Y., Aji, T., et al. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104198 · Cited by 56
The expanding landscape of inflammatory cells affecting cancer therapy
Weissleder, R., & Pittet, M. J. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0524-y · Cited by 55
Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells
Chen, F., Ding, K., Priedigkeit, N., Elangovan, A., Levine, K. M., Carleton, N. M., Savariau, L., Atkinson, J. M., Oesterreich, S., & Lee, A. V. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0696 · Cited by 53
Guo, Y., Li, Y., Cai, B., He, Q., Chen, G., Wang, M., Wang, K., Wan, X., & Yan, Q. (2021) · Aging · doi:10.18632/aging.202288 · Cited by 55
“Cell-to-cell correlations constructed from gene expression of the stromal single cells revealed separation of cells by cell-types while not by sample origin, suggesting that most stromal cell type populations were shared by different patients (Supplementary Figure 3C) [20].”
Mapping Breast Cancer Microenvironment Through Single-Cell Omics
Tan, Z., Chen, K., Sun, M., Yang, F., Wong, M., Wang, S., & Zheng, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868813 · Cited by 62
“M2-type genes, such as CD276, CD163, MS4A6A, and TGFB1, are widely expressed in tumorassociated macrophages and showed the characteristics of cascade M2 differentiation (32, 34, 43).”
BackgroundSOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function
Xue, Y., Lai, L., Lian, W., Tu, X., Zhou, J., Dong, P., Su, D., Wang, X., Cao, X., Chen, Y., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0610 · Cited by 50
Identifying cell types to interpret scRNA-seq data: how, why and more possibilities
Wang, Z., Ding, H., & Zou, Q. (2020) · Briefings in Functional Genomics · doi:10.1093/bfgp/elaa003 · Cited by 60
Macrophage states: there's a method in the madness
Katkar, G. D., & Ghosh, P. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.10.006 · Cited by 55
Torang, A., Gupta, P., & Klinke, D. J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2994-z · Cited by 80
Microfluidic single-cell transcriptomics: moving towards multimodal and spatiotemporal omics
Lin, S., Liu, Y., Zhang, M., Xu, X. J., Chen, Y., Zhang, H., & Yang, C. J. (2021) · Lab on a Chip · doi:10.1039/d1lc00607j · Cited by 52
Das, S., Camphausen, K. A., & Shankavaram, U. T. (2020) · Cancers · doi:10.3390/cancers12092476 · Cited by 57
“The scRNA-Seq data for 11 breast cancer patient samples were collected from Chung and colleagues’ published transcriptomic data of 549 single cells [12] deposited in the Gene Expression Omnibus (accession: GSE75688).”
MethodEpigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe
Niu, Y., Chen, J., & Qiao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836223 · Cited by 53
Comparative characterization of 3D chromatin organization in triple-negative breast cancers
Kim, T., Han, S., Chun, Y., Yang, H.-J., Min, H., Jeon, S. Y., Kim, J., Moon, H., & Lee, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00768-2 · Cited by 53
Jackson, C. M., Pant, A., Dinalankara, W., Choi, J. H., Jain, A., Nitta, R. T., Yazigi, E., Saleh, L., Zhao, L., Nirschl, T. R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.07.003 · Cited by 58
Wu, H., Yu, J., Li, Y., Hou, Q., Zhou, R., Zhang, N., Zhao, J., Jiang, M., Li, Z., Hua, Y., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.017 · Cited by 50
Transcriptome and Regulatory Network Analyses of CD19-CAR-T Immunotherapy for B-ALL
Zhang, Q., Hu, H., Chen, S., Liu, C., Hu, F., Yu, J., Wu, Y., & Guo, A. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.12.008 · Cited by 48
Pang, B., Xu, J., Hu, J. R., Guo, F., Wan, L., Cheng, M., & Pang, L. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12569 · Cited by 49
“Instead, single-cell RNA sequencing (scRNA-seq) generates gene expression profiles at the resolution of an individual cell (Tang et al., 2009), which has been comprehensively applied to reveal the heterogeneity of diverse cancers (Chung et al., 2017; Li et al., 2017; Patel et al., 2014).”
BackgroundLombardo, J. A., Aliaghaei, M., Nguyen, Q., Kessenbrock, K., & Haun, J. B. (2021) · Nature Communications · doi:10.1038/s41467-021-23238-1 · Cited by 56
Rye, I. H., Huse, K., Josefsson, S. E., Kildal, W., Danielsen, H. E., Schlichting, E., Garred, Ø., Riis, M. L. H., OSBREAC, Lingjærde, O. C., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13047 · Cited by 48
Oshi, M., Newman, S., Murthy, V., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., & Takabe, K. (2020) · Cancers · doi:10.3390/cancers12102758 · Cited by 46
Holo-Seq: single-cell sequencing of holo-transcriptome
Xiao, Z., Cheng, G., Yang, J., Pan, C., Li, R., Jia, D., Zhu, J., Wu, C., Zheng, M., & Jia, J. (2018) · Genome biology · doi:10.1186/s13059-018-1553-7 · Cited by 47
“Although single-cell mRNA sequencing has provided many insights into the neoplastic progression and therapy of cancers [2, 37], the heterogeneity of miRNAs and its relationship with mRNA transcriptome in cancer still Fig.”
BackgroundKumegawa, K., Takahashi, Y., Saeki, S., Yang, L., Nakadai, T., Osako, T., Mori, S., Noda, T., Ohno, S., Ueno, T., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00438-6 · Cited by 45
“2, (5) the cells were projected onto UMAP embedding space by RunUMAP() with 1–50 dimensions.”
Xu, J., Qin, S., Yi, Y., Gao, H., Liu, X., Ma, F., & Guan, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179936 · Cited by 47
“Researchers have used scRNA-seq to analyze the tumor heterogeneity of different subtypes of BC and identified cell clusters associated with poor prognosis or treatment response [21,22].”
MethodThe latest animal models of ovarian cancer for novel drug discovery
Magnotti, E. L., & Marasco, W. A. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1426567 · Cited by 45
An assessment of prognostic immunity markers in breast cancer
Yang, B., Chou, J.-H., Tao, Y., Wu, D.-B., Wu, X., Li, X., Yan, L., Chu, Y., Tang, F., Shi, Y., et al. (2018) · npj Breast Cancer · doi:10.1038/s41523-018-0088-0 · Cited by 47
“Single-cell expression of the 72 genes was also analyzed in 11 tumor samples containing 12 to 78 single cells.(27) The subtype of each bulk tumor was defined by immunohistochemistry (IHC) in the original paper, identifying 2 LumA, 1 LumB, 4 HER2E and 4 triple-negative breast cancers (TNBC).”
BackgroundInfluentialPreclinical models and technologies to advance nanovaccine development
Peres, C., Matos, A. I., Moura, L. I. F., Acúrcio, R. C., Carreira, B., Pozzi, S., Vaskovich‐Koubi, D., Kleiner, R., Satchi‐Fainaro, R., & Florindo, H. F. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.001 · Cited by 48
Dang, M. T., Gonzalez, M. V., Gaonkar, K. S., Rathi, K. S., Young, P. A., Arif, S., Zhai, L., Alam, Z., Devalaraja, S., To, T. K. J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108917 · Cited by 46
“Single-cell RNA sequencing (scRNA-seq) overcomes this limitation and is beginning to provide unprecedented insight into cellular heterogeneity in solid tumors (Chung et al., 2017; Gubin et al., 2018).”
BackgroundLv, J., Shi, Q., Han, Y., Li, W., Liu, H., Zhang, J., Niu, C., Gao, G., Fu, Y., Zhi, R., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04380-6 · Cited by 49
B-Cell-Based Immunotherapy: A Promising New Alternative
Gupta, S. L., Khan, N., Basu, S., & Soni, V. (2022) · Vaccines · doi:10.3390/vaccines10060879 · Cited by 51
Evaluating imputation methods for single-cell RNA-seq data
Yi, C. X., Ma, X., Yuan, L., Sun, Z., & Wang, P. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05417-7 · Cited by 58
“In addition, to evaluate how much the intrinsic structure can be discriminated based on the marker genes after imputation, we also calculated silhouette scores based on the discriminated cell clusters for datasets PBMC, ILC, Melanoma.2 and BRCA (Fig.”
BackgroundInfluentialApplication of single-cell sequencing in human cancer
Rantalainen, M. (2017) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx036 · Cited by 51
IRIS3: integrated cell-type-specific regulon inference server from single-cell RNA-Seq
Ma, A., Wang, C., Chang, Y., Brennan, F. H., McDermaid, A., Liu, B., Zhang, C., Popovich, P. G., & Ma, Q. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa394 · Cited by 44
Davidov, V., Jensen, G. L., Mai, S., Chen, S., & Pan, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01842 · Cited by 47
“This distinct proangiogenic TAM subset, identified by surface TIE2 expression, secretes classic proangiogenic factors, such as VEGF proteins and SEMA4D (86, 87).”
BackgroundOshi, M., Angarita, F. A., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., & Takabe, K. (2020) · Cancers · doi:10.3390/cancers12123856 · Cited by 46
“Single cell sequencing data were obtained from primary breast cancer tumor from the GSE75688 cohort [48].”
Application of single-cell sequencing to the research of tumor microenvironment
Chen, S., Zhou, Z., Li, Y., Du, Y., & Chen, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285540 · Cited by 51
Single‐Cell Multi‐Omics and Its Prospective Application in Cancer Biology
Peng, A., Mao, X., Zhong, J., Fan, S., & Hu, Y. (2020) · PROTEOMICS · doi:10.1002/pmic.201900271 · Cited by 50
The emerging role of RNA N6-methyladenosine methylation in breast cancer
Zheng, F., Du, F., Zhao, J., Wang, X. L., Si, Y., Peng, J., Qian, H., Xu, B., & Yuan, P. (2021) · Biomarker Research · doi:10.1186/s40364-021-00295-8 · Cited by 46
Zhu, X., Tian, X., Ji, L., Zhang, X., Cao, Y., Shen, C., Hu, Y., Wong, J. W. H., Fang, J.-Y., Hong, J., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00142-x · Cited by 41
Beyes, S., Bediaga, N. G., & Zippo, A. (2021) · Cancers · doi:10.3390/cancers13194969 · Cited by 50
“Recent scRNA-seq experiments have confirmed that tumours constitute a complex and heterogeneous ecosystem, with a subpopulation of cells showing treatment-resistant properties [119], as well as heterogeneous patterns of immune infiltration [114,119,120] and overall cellular composition [12] that are relevant to tumour…”
BackgroundVerstegen, N. J. M., Pollastro, S., Unger, P. A., Marsman, C., Elias, G., Jorritsma, T., Streutker, M., Bassler, K. E., Händler, K., Rispens, T., et al. (2023) · eLife · doi:10.7554/elife.83578 · Cited by 51
“To date, single-cell sequencing has been used, among others, to identify B cell subsets in the immune landscape of tumor-infiltrating lymphocytes (Chung et al., 2017), to delineate malignant B cells in follicular lymphomas (Andor et al., 2019), and to identify transiting bone marrow progenitor cell…”
MethodLin, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087001 · Cited by 53
Functional Roles of SPINK1 in Cancers
Lin, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083814 · Cited by 51
Yuan, T., Fu, X., Hu, R., Zheng, X., Jiang, D., Jing, L., Kuang, X., Guo, Z., Xu, L., Liu, Y., et al. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.06.007 · Cited by 52
Single-Cell Clustering Based on Shared Nearest Neighbor and Graph Partitioning
Zhu, X., Zhang, J., Xu, Y., Wang, J., Peng, X., & Li, H. (2020) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-019-00357-4 · Cited by 46
Oshi, M., Patel, A. P., Wu, R., Le, L. M., Tokumaru, Y., Yamada, A., Yan, L., Matsuyama, R., Ishikawa, T., Endo, I., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00466-2 · Cited by 43
Yang, S., Wang, M., Hua, Y., Li, J., Zheng, H., Cui, M., Huang, N., Liu, Q., & Liao, Q. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216610 · Cited by 48
Isaic, A., Motofelea, N., Hoinoiu, T., Motofelea, A. C., Leancu, I. C., Stan, E., Gheorghe, S. R., Duţu, A., & Crintea, A. (2025) · Diagnostics · doi:10.3390/diagnostics15192425 · Cited by 57
“Traditional statistical methods, combined with machine learning and AI, are increasingly applied to RNA-Seq data to build predictive scoring systems for prognosis and therapy response, particularly for immune checkpoint inhibitors (ICIs) such as PD-1/PD-L1 therapies [102,103].”
Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
Lee, M., Park, C., Woo, J., Kim, J.-H., Kho, I., Nam, D., Park, W., Kim, Y.-S., Kong, D., Lee, H. W., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00555 · Cited by 41
Self-citationYan, X., Xie, Y., Yang, F., Hua, Y., Zeng, T., Sun, C., Yang, M., Huang, X., Wu, H., Fu, Z., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01949-z · Cited by 47
scTPA: a web tool for single-cell transcriptome analysis of pathway activation signatures
Zhang, Y., Zhang, Y., Hu, J. S., Zhang, J., Guo, F., Zhou, M., Zhang, G., Yu, F., & Su, J. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa532 · Cited by 39
Ruan, H., Wang, Z., Sun, Z., Wei, J., Zhang, L., Ju, H., Wang, T., Zhang, C., Guan, M., & Pan, S. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.885 · Cited by 42
Lactate from glycolysis regulates inflammatory macrophage polarization in breast cancer
Wang, C., Xue, L., Zhu, W., Liu, L., Zhang, S., & Luo, D. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03382-x · Cited by 41
“5b), which was consistent with previous reports in the literature [54].”
ResultHong, D., Kim, H. K., Yang, W., Yoon, C., Kim, M., Yang, C., & Yoon, S. (2024) · Communications Biology · doi:10.1038/s42003-024-06409-w · Cited by 47
Shi, W., Zhang, Z., Xu, X., Tian, Y., Feng, L., Huang, X., Du, Y., & Li, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1649468 · Cited by 56
Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
Pompella, L., Tirino, G., Pappalardo, A., Caterino, M., Ventriglia, A., Nacca, V., Orditura, M., Ciardiello, F., & Vita, F. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082814 · Cited by 43
Tutorial: Guidelines for Single-Cell RT-qPCR
Žucha, D., Kubista, M., & Valihrach, L. (2021) · Cells · doi:10.3390/cells10102607 · Cited by 43
Hao, K.-J., Jia, X. P., Dai, W.-T., Huo, Z.-M., Zhang, H., Liu, J., & Wang, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.689553 · Cited by 44
Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast Cancer
Hinshaw, D. C., Benavides, G. A., Metge, B. J., Swain, C. A., Kammerud, S. C., Alsheikh, H. A., Elhamamsy, A. R., Chen, D., Darley-Usmar, V. M., Rathmell, J. C., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0426 · Cited by 43
Wang, M., Deng, W., Samuels, D. C., Zhao, Z., & Simon, L. M. (2023) · Genes · doi:10.3390/genes14061222 · Cited by 50
“[18] studied tumor heterogeneity in eleven breast cancer patients and their data contained profiles from both bulk DNAseq and scRNAseq of the same individuals.”
BackgroundMethodAmmons, D. T., Hopkins, L. S., Cronise, K. E., Kurihara, J. N., Regan, D. P., & DOW, S. W. (2024) · Communications Biology · doi:10.1038/s42003-024-06182-w · Cited by 44
Luo, Y., Tian, W., Kang, D., Wu, L., Tang, H., Wang, S., Zhang, C., Xie, Y., Zhang, Y., Xie, J., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.029 · Cited by 45
The function and potential drug targets of tumour-associated Tregs for cancer immunotherapy
Yan, S., Zhang, Y., & Sun, B. (2019) · Science China Life Sciences · doi:10.1007/s11427-018-9428-9 · Cited by 40
Yin, Y., Liu, P., Shi, Y., & Li, P. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_47 · Cited by 44
Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression
Arora, L., & Pal, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.596798 · Cited by 43
Mahin, K. F., Robiuddin, M., Islam, M., Ashraf, S., Yeasmin, F., & Shatabda, S. (2022) · Genomics · doi:10.1016/j.ygeno.2022.01.001 · Cited by 39
Ahmadi, S., Sukprasert, P., Vegesna, R., Sinha, S., Schischlik, F., Artzi, N., Khuller, S., Schäffer, A. A., & Ruppin, E. (2022) · Nature Communications · doi:10.1038/s41467-022-29154-2 · Cited by 41
Cell Trafficking at the Intersection of the Tumor–Immune Compartments
Du, W., Nair, P. R., Johnston, A. C., Wu, P., & Wirtz, D. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110320-110749 · Cited by 41
“Most in vivo assays for migration consist essentially of a black box, as they largely rely on endpoints (44-48) and are unable to distinguish chemotaxis from random migration (Figure 4).”
BackgroundMoncada, R., Wagner, F., Chiodin, M., Devlin, J. C., Baron, M., Hajdu, C. H., Simeone, D. M., & Yanai, I. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/254375 · Cited by 40
Cancer cell states and emergent properties of the dynamic tumor system
Barkley, D., Rao, A. N., Pour, M., França, G. S., & Yanai, I. (2021) · Genome Research · doi:10.1101/gr.275308.121 · Cited by 43
“For example, individual breast tumors harbor cells with transcriptional profiles corresponding to all fourmolecular subtypes: “basal,” “luminal A,” “luminal B,” and “HER2” (Chung et al. 2017; Gao et al. 2017), highlighting the importance of studying tumors at cellular resolution.”
BackgroundTranscriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers
Lee, K.-H., Park, H.-M., Son, K. H., Shin, T.-J., & Cho, J. (2018) · Cancers · doi:10.3390/cancers10090317 · Cited by 37
“, publicly opened project (PRJNA305054) in the National Center for Biotechnology Information (NCBI) [28].”
BackgroundSelf-citation
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.